0001209191-23-036425.txt : 20230612
0001209191-23-036425.hdr.sgml : 20230612
20230612173911
ACCESSION NUMBER: 0001209191-23-036425
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230612
DATE AS OF CHANGE: 20230612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bleil Lynn Dorsey
CENTRAL INDEX KEY: 0001607309
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 231009509
MAIL ADDRESS:
STREET 1: 333 WEST 11TH STREET
CITY: KANSAS CITY
STATE: MO
ZIP: 64105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (215) 921-7600
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
FORMER COMPANY:
FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC
DATE OF NAME CHANGE: 20020729
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-08
0
0001178879
AMICUS THERAPEUTICS, INC.
FOLD
0001607309
Bleil Lynn Dorsey
C/O AMICUS THERAPEUTICS, INC.
3675 MARKET STREET
PHILADELPHIA
PA
19104
1
0
0
0
0
Common Stock
2023-06-08
4
A
0
8584
0.00
A
81680
D
Stock Options (right to buy)
12.62
2023-06-08
4
A
0
30474
0.00
A
2033-06-08
Common Stock
30474
30474
D
Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.
Christian Formica, Attorney-in-Fact
2023-06-12